Arcellx, Inc. (ACLX)
114.33
-0.03
(-0.03%)
USD |
NASDAQ |
Mar 06, 16:00
114.99
+0.66
(+0.58%)
After-Hours: 20:00
Arcellx SG&A Expense (TTM) : 117.76M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Eli Lilly & Co. | 11.09B |
| Johnson & Johnson | 23.68B |
| Merck & Co., Inc. | 10.73B |
| Amicus Therapeutics, Inc. | 383.49M |